Atrial fibrillation refers to an irregular heartbeat that may result in blood clots, stroke, heart failure, and other heart-related complications. Some common causes of atrial fibrillation are in-take of the unhealthy diet, high blood pressure, sleep apnea, lack of exercise, smoking, alcohol abuse, and so on. Valvular heart disease and hypertension are the most common risk factors for atrial fibrillation disease. The geriatric population is at increased risk of developing heart disease, atrial fibrillation. According to the Centers for Disease Control and Prevention (CDC), an estimated 2.7–6.1 million people in the US have atrial fibrillation. With the aging of the U.S. population, this number is expected to increase. For instance, approximately 2% of people younger than age 65 have atrial fibrillation, while about 9% of people aged 65 years or older have atrial fibrillation. Therefore, the rise in the prevalence of atrial fibrillation coupled with increasing geriatric population is one of the major factors contributing to the growth of the market.

The global atrial fibrillation devices market is segmented on the basis of product and end-user. On the basis of products, the market is further segmented into electrophysiology ablation catheters, electrophysiology diagnostic catheters, electrophysiology, mapping and recording systems, cardiac monitors, and others. Among these, electrophysiology ablation catheters are expected to generate considerable value in terms of revenue during the forecast period. The prominent share of the segment is attributed to increasing number of catheter ablation procedures performed as it is minimally invasive in nature which results in increased safety and faster recovery of patients. Moreover, the adoption of several cardiac monitors, such as Holter monitor and mobile cardiac telemetry (MCT) for monitoring the heart rhythms are expected to drive the growth of the cardiac monitor’s segment during the forecast period.

The global atrial fibrillation devices market is further analyzed on the basis geographical regions, including North America, Europe, Asia-Pacific and RoW. North America being the early adopter of the advanced technology. There is a significant adoption of minimally invasive procedures in the region due to well-developed healthcare infrastructure and significant focus on patients’ safety in the region. This results in the rising demand for atrial fibrillation devices in the region. In addition, well-established healthcare infrastructure and the presence of key players such as Johnson & Johnson, Abbott Laboratories Inc., and Boston Scientific Corp. in the region further supporting to boost the growth of the market in the region. Moreover, Asia-Pacific is expected to exhibit considerable growth during the forecast period. The regional growth of the market is attributed to the rising geriatric population and increasing healthcare expenditure in the region.

Abbott Laboratories Inc., Johnson & Johnson, Boston Scientific Corp., Siemens AG, Medtronic PLC, AtriCure, Inc., Microport Scientific Corp., and Koninklijke Philips N.V. are some of the major players operating in the global atrial fibrillation devices market. These players hold a prominent share of the overall market owing to robust product offering and strong position in the medical device sector.

Research Methodology

The market study of the global atrial fibrillation devices market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include

• Financial reports of companies involved in the market
• Authenticate databases such as the American Heart Association, the World Health Organization (WHO), and others.
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog

The report is intended for healthcare organizations, medical device manufacturers, original equipment manufacturers (OEM), market research firms, investment companies, government societies for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation

Global Atrial Fibrillation Devices Market Research and Analysis by Product

Global Atrial Fibrillation Devices Market Research and Analysis by End-User

The Report Covers

• Comprehensive research methodology of the global atrial fibrillation devices
  
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global atrial fibrillation devices market.
• Insights about market determinants which are stimulating the global atrial fibrillation devices
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.